innovation for industry
Articles ＆ files | Focus | Article
Computational Lensfree Microscopy
Imaging technology for point-of-care analysis and pathology screening
Thanks to its extra-wide field of view and compact footprint, combined with artificial intelligence-based algorithms, CEA-Leti’s lensfree imaging allows healthcare professionals to perform point-of-care tests that previously were done in the lab. In addition, the technology is more than 10 times less expensive than an optical microscope and can image up to 10,000 microscopic biological objects at a time. This innovation is protected by 25 patents.
Point-of-care testing: The technique, using only generic hardware, can be adapted to different medical diagnostics by developing specific data-processing chains for tests like:
• Complete blood count (developed in partnership with Horiba)
• Meningitis screening from spinal fluid (developed in partnership with Marseille-e University Medical Center)
• Blood coagulation test (developed in partnership with startup Avalun)
Other healthcare applications: • Monitoring of bioprocesses in bioreactors for
the pharmaceutical industry: cell counts, cell viability
(developed in partnership with startup Iprasense)
• 2D imaging for standard biological research and drug
screening: cell counts, motility, viability, dry mass,
cell-cycle duration, etc.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.